Please login to the form below
Phillip Frost to remain chair of Teva Pharmaceutical
Re-elected by board for at least three more years
Dr Phillip Frost has been re-elected as chair of Teva Pharmaceutical.
The Israel-based firm's board of directors unanimously voted for Dr Frost to remain in the position for at least three more years, subject to shareholder approval.
He has served as chair since March 2010, having previously been vice chair from January 2006.
Prior to his time at Teva, he was chair and CEO of IVAX Xorporate from 1987 to 2006.
The board's vice chair, Professor Moshe Many, said: “Dr Phillip Frost has the Board's full support. We would continue to benefit from his vision and guidance.
“We look forward to the progress of the company under the governance of the Board and the leadership of Teva's President and CEO Dr. Jeremy Levin.”
Dr Frost's continuation provides Teva with some stability as former senior vice president of strategy at Bristol-Myers Squibb, Jeremy Levin, begins his tenure as the company's CEO and president.
The company has also recently appointed genetics expert Dr Michael Hayden as its first president of global R&D and chief scientific officer.
Share
Related Hub content
Featured jobs
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Account Director or Senior Account Director
-
Salary TBC
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Account Manager
-
Negotiable
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Systematic Review Lead- London
-
Negotiable
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Associate Scientific Director
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
Subscribe to our email news alerts
- Moving annual total (MAT)
- AZ prepares to file COPD triple, taking on rival GSK
- J&J files ‘breakthrough’ bladder cancer drug in US
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Teva wins FDA OK for crucial migraine drug
- NHS wins legal fight with pharma over off-label Avastin
- 3MZ Healthcare Communications: Improving Human Care
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
